Docusign target cut to $56 from $62, UBS maintains Neutral By Investing.com

On Friday, UBS adjusted its outlook on Docusign Inc. (NASDAQ: DOCU), reducing the price target to $56 from the previous $62, while keeping a Neutral rating on the stock. The adjustment follows recent market trends where software firms have shown a pattern of weak growth rates, which investors had anticipated might reflect in Docusign’s performance as well.

The company’s first-quarter results, which included the month of April, showed a sequential drop in total revenues for the first time. Despite this, Docusign managed to slightly surpass revenue expectations, and its billings were at the lower end of the historical range. The UBS analyst noted that while the quantitative data was somewhat disappointing, qualitative comments from the company painted a more positive picture, highlighting steady demand and improvements in electronic signature volumes and net revenue retention, with stable trends observed in April and May.

DocuSign (NASDAQ:)’s valuation currently stands at 11 times the revised cash flow estimates for the calendar year 2025 and fiscal year 2026. UBS believes this multiple to be reasonable given the company’s growth profile, which has led to the decision to maintain a Neutral stance on the stock.

The reduction in the price target reflects the cautious stance taken by UBS in light of both the company’s recent performance and the broader industry signals. DocuSign, known for its electronic signature solutions, has been navigating the shifting dynamics of the software sector, which has seen varying degrees of growth and investor sentiment in recent times.

In other recent news, Docusign reported a 7% increase in Q1 revenue to $710 million, along with an 8% rise in subscription revenue to $691 million. The company also launched the DocuSign Intelligent Agreement Management (IAM) platform and acquired AI technology leader Lexion. However, Baird, RBC Capital Markets, and BofA Securities have all adjusted their outlook on Docusign, reducing their price targets due to modest earnings results and a shift in guidance philosophy. These firms maintain a neutral rating on the stock.

Docusign’s dollar net retention rate reached 99%, and it generated $232 million in free cash flow. The company has provided positive guidance for Q2 and the full fiscal year, expecting revenue between $725 million and $729 million for Q2, and between $2.920 billion and $2.932 billion for fiscal 2025. These recent developments highlight Docusign’s commitment to maintaining a leading position in the agreement management space.

InvestingPro Insights

DocuSign Inc . (NASDAQ: DOCU) presents a mixed financial picture according to recent InvestingPro data. With a market capitalization of $10.62 billion, the company’s valuation metrics show a high P/E ratio of 98.81, indicating investor optimism about future earnings potential despite current earnings levels. This is further reflected in the adjusted P/E ratio for the last twelve months as of Q4 2024, standing at 106.77. Nevertheless, DocuSign boasts an impressive gross profit margin of 80.4%, underscoring the company’s ability to maintain profitability in its core operations.

InvestingPro Tips highlight that DocuSign holds more cash than debt on its balance sheet, suggesting a strong liquidity position. Additionally, the company’s net income is expected to grow this year, which could be a positive sign for investors looking for growth potential. With these factors in mind, readers interested in a deeper analysis can find additional insights and tips on InvestingPro, where there are 13 more tips available for DocuSign. These tips could provide valuable context to the company’s financial health and future prospects. For those considering an InvestingPro subscription, use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.